Jun 16, 2020
CAR-T Therapy Market Outlook to 2030 by Target Antigen, Application, Region, Country and Company
May 27, 2020
ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp.
May 18, 2020
CARsgen Therapeutics Receives IND Clearance from the US FDA for CT041 CLDN18.2-CAR-T Cells
Mar 31, 2020
MEI Pharma Announces Fast Track Designation Granted by U.S. FDA for ME-401 For the Treatment of Adult Patients with Relapsed or Refractory Follicular Lymphoma
Mar 29, 2020
Ascentage Pharma Releases 2019 Annual Results, Reports Increased Investment in R&D and Advances in Global Clinical Development
Mar 16, 2020
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
Mar 11, 2020
Creative Medical Technology Holdings Announces IMMCELZ(TM) Adoptive Immunotherapy Product
Jan 28, 2020
2019 CAR-T Cell Therapy Market Study: Current Status, Patent Landscape, Funding, Deals, Research, Applications, Technologies, Marketed Products, Ongoing & Late Stage Clinical Trials
Jan 10, 2020
PACT Pharma Raises $75M in Oversubscribed Series C Financing to Develop Fully Personalized NeoTCR-T Cell Therapies for Patients with Cancer
Jan 06, 2020
Global Cancer Immunotherapy Market is Forecast to hit $115 Billion by 2023 - ReportsnReports
Nov 20, 2019
Ascentage Pharma Breaks Ground on its Global Headquarters, R&D Center and Manufacturing Facility in the Suzhou Industrial Park
Nov 18, 2019
MimiVax LLC and Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. announce exclusive licensing agreement on SurVaxM for glioblastoma treatment in China
Nov 12, 2019
Marker Therapeutics Reports Third Quarter 2019 Operating and Financial Results
Nov 05, 2019
A2 Biotherapeutics Emerges From Stealth Mode With $57M Series A To Develop A Pipeline Of Selective Tumor Cell Therapeutics
Oct 02, 2019
PACT Pharma Appoints Tim Moore as President and Chief Technical Officer
Aug 30, 2019
CARsgen Therapeutics Receives US FDA Orphan Drug Designation For Fully Human Anti-BCMA (B Cell Maturation Antigen) Autologous Chimeric Antigen Receptor (CAR) T Cells For The Treatment Of Multiple Myeloma
Aug 28, 2019
The CAR-T Therapies Market is Projected to Reach USD 11 Billion by 2030, Growing at an Annualized Rate of 31%, Claims Roots Analysis
Aug 15, 2019
Marker Therapeutics Appoints Nadia Agopyan, Ph.D., RAC as Vice President of Regulatory Affairs
Aug 07, 2019
Global $1.01 Billion Cell and Gene Therapy Market 2019-2025: Steady Investment and Consolidation in the Market
Aug 01, 2019
The T-cell Immunotherapies Market is Projected to Reach USD 26 Billion by 2030, Growing at an Annualized Rate of 41.5%, Claims Roots Analysis